Edition:
India

People: CSPC Pharmaceutical Group Ltd (1093.HK)

1093.HK on Hong Kong Stock

9.01HKD
20 Oct 2020
Change (% chg)

HK$0.08 (+0.90%)
Prev Close
HK$8.93
Open
HK$8.93
Day's High
HK$9.05
Day's Low
HK$8.81
Volume
36,725,212
Avg. Vol
61,214,869
52-wk High
HK$11.35
52-wk Low
HK$6.83

Cai, Dongchen 

Mr. Dongchen Cai serves as Executive Chairman of the Board, Chief Executive Officer of the Company. Mr. Cai was appointed as an executive director of the Company in 1998. Mr. Cai is also the chairman of the Nomination Committee of the Company and a director of certain subsidiaries of the Group. Mr. Cai holds a MBA degree from Nankai University and has extensive technical and management experience in the pharmaceutical industry. Mr. Cai is a substantial shareholder of the Company within the meaning of Part XV of the Securities and Futures Ordinance (“SFO”). Mr. Cai is also a director of True Ally Holdings Limited and Massive Giant Group Limited, both are substantial shareholders of the Company within the meaning of Part XV of the SFO.

Basic Compensation

Total Annual Compensation, CNY 11,759,000
Restricted Stock Award, CNY --
Long-Term Incentive Plans, CNY --
All Other, CNY 390,000
Fiscal Year Total, CNY 12,149,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Dongchen Cai

12,149,000

Cuilong Zhang

6,527,000

Kin Man Chak

4,857,000

Chunlei Li

4,779,000

Weidong Pan

3,906,000

Huaiyu Wang

3,890,000
As Of  31 Dec 2019